MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

ACG Roundup: Young-Onset Barrett’s Esophagus on the Rise

Research presented at the annual American College of Gastroenterology (ACG) meeting in Philadelphia included studies on the increasing incidence of young-onset Barrett’s esophagus in the

November 5, 2024

Denial of Lykos’ MDMA-Assisted PTSD Therapy Followed by Retraction of Related Studies | Psychedelic Invest

A day after the regulatory rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD, the scientific community faced another setback as a prominent medical journal retracted

August 12, 2024

Wastewater testing specifically for bird flu virus will scale up nationally in coming weeks

Less than a month ago, researchers reported for the first time the ability to scan wastewater for signs of the H5 influenza virus currently sickening

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.